Patents by Inventor Anthony Keller
Anthony Keller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250042209Abstract: An amphibious vehicle that can be operated in a variety of conditions and terrain, including on land and in water, includes a high visibility cab portion, a chassis, and prime mover. The amphibious vehicle has two rows of forward-facing seats situated inside the cab portion, allowing both the operator and passengers to look outside via the high visibility cab portion. A CVT and steering-wheel interface for steering is utilized to provide the operator with an intuitive driving experience.Type: ApplicationFiled: March 14, 2024Publication date: February 6, 2025Applicant: Ontario Drive & Gear LimitedInventors: Brian William DICK, Nikolas Couturier MCCLUSKEY, Jason Alexander BONIN, Claude Pierre BEAUDOIN, Shawn Anthony MONAHAN, Alexander Thomas OPRATKO, Dayne Bradley EFTA, Daniel Wayne DOTZERT, Jeremy Damon BAUMAN, Ryan Matthew SOLTAU, Justin Michael KUNZ, Michael Kevin SCHLEY, Dustin Donald KELLER, Paul Calvin ECKSTEIN, Keith Louis HEIBEIN, Brett STOLTZ, Carlos Augusto ROJAS NINO, Michael Aaron BRATENG
-
Patent number: 12213510Abstract: The disclosure provides products configured for oral use, the products including a mixture of a particulate filler, water, one or more organic acids, and one or more flavoring agents, the product having a pH value of less than about 7.0. The products exhibit greater stability over time with respect to whiteness and/or flavor component concentration than products which do not contain one or more organic acids.Type: GrantFiled: September 11, 2019Date of Patent: February 4, 2025Assignee: NICOVENTURES TRADING LIMITEDInventors: Christopher Keller, Thomas H. Poole, Ronald K. Hutchens, Anthony R. Gerardi
-
Patent number: 12194505Abstract: A computer-implemented method can be used for controlling sorting of plastic compounds. The method involves providing a computer-based database containing entries on a plurality of markers each identifying a specific plastic compound; receiving scan data from a sample of a plastic compound; identifying a marker in the sample of the plastic compound based on the received scan data and the plurality of markers of the database; and sorting of plastic compounds based on the identified marker of the sample of the plastic compound.Type: GrantFiled: November 19, 2021Date of Patent: January 14, 2025Assignee: BASF SEInventors: Gazi Tuerkoglu, Marina Grace Dickens Leed, Wilhelm Keller, Martina Solfrank, Robert Anthony Keller, Oliver Reich, David Leino Calleja, Li Noi Lilian Hoh, Oliver Kuhn, Shyam Sundar Sathyanarayana, Kai Pahnke, Tobias Eltze, Christian Beil
-
Publication number: 20240013128Abstract: A computer-implemented method can be used for determining a sustainability score. The method involves providing a computer-based database containing entries on a plurality of markers each identifying a specific plastic compound; receiving scan data from a sample of a plastic compound; identifying a marker in the sample of the plastic compound based on the received scan data and the plurality of markers of the database; and determining a sustainability score based on the identified marker of the sample of the plastic compound.Type: ApplicationFiled: November 19, 2021Publication date: January 11, 2024Applicant: BASF SEInventors: Marina Grace Dickens Leed, Gazi Tuerkoglu, Wilhelm Keller, Martina Solfrank, Robert Anthony Keller, Oilver Reich, David Leino Calleja, Li Noi Lilian Hoh, Oliver Kuhn, Shyam Sundar Sathyanarayana, Kai Pahnke, Tobias Eltze, Christian Beil
-
Publication number: 20240009710Abstract: A computer-implemented method can be used for controlling sorting of plastic compounds. The method involves providing a computer-based database containing entries on a plurality of markers each identifying a specific plastic compound; receiving scan data from a sample of a plastic compound; identifying a marker in the sample of the plastic compound based on the received scan data and the plurality of markers of the database; and sorting of plastic compounds based on the identified marker of the sample of the plastic compound.Type: ApplicationFiled: November 19, 2021Publication date: January 11, 2024Applicant: BASF SEInventors: Gazi TUERKOGLU, Marina Grace Dickens Leed, Wilhelm Keller, Martina Solfrank, Robert Anthony Keller, Oliver Reich, David Leino Calleja, Li Noi Lilian Hoh, Oliver Kuhn, Shyam Sundar Sathyanarayana, Kai Pahnke, Tobias Eltze, Christian Beil
-
Publication number: 20230240984Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.Type: ApplicationFiled: October 28, 2022Publication date: August 3, 2023Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
-
Publication number: 20200297625Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.Type: ApplicationFiled: January 27, 2020Publication date: September 24, 2020Applicant: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
-
Patent number: 10596109Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.Type: GrantFiled: December 1, 2017Date of Patent: March 24, 2020Assignee: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
-
Publication number: 20180214373Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.Type: ApplicationFiled: December 1, 2017Publication date: August 2, 2018Applicant: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
-
Publication number: 20180092838Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.Type: ApplicationFiled: November 22, 2017Publication date: April 5, 2018Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
-
Patent number: 9855212Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.Type: GrantFiled: October 29, 2010Date of Patent: January 2, 2018Assignee: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
-
Patent number: 9839609Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.Type: GrantFiled: October 29, 2010Date of Patent: December 12, 2017Assignee: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
-
Patent number: 8524657Abstract: The present invention provides a compound of formula I, II, III and IV as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.Type: GrantFiled: August 2, 2011Date of Patent: September 3, 2013Assignee: University of WollongongInventors: Timothy Patrick Boyle, John Barnard Bremmer, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Joseph Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
-
Publication number: 20130045941Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.Type: ApplicationFiled: October 29, 2010Publication date: February 21, 2013Applicant: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
-
Publication number: 20120207827Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.Type: ApplicationFiled: October 29, 2010Publication date: August 16, 2012Applicant: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
-
Patent number: 8217085Abstract: Embodiments of the invention relate generally to the use of compositions comprising methylsulfonylmethane (MSM), and one or more therapeutic agents, for the treatment of drug-sensitive and drug resistant microorganisms. In several embodiments, such compositions are effective in treating drug resistant infectious diseases, for example, MRSA.Type: GrantFiled: February 17, 2012Date of Patent: July 10, 2012Assignee: Biogenic Innovations, LLCInventors: Rodney Benjamin, Jeffrey Varelman, Anthony Keller
-
Publication number: 20120149672Abstract: Embodiments of the invention relate generally to the use of compositions comprising methylsulfonylmethane (MSM), and one or more therapeutic agents, for the treatment of drug-sensitive and drug resistant microorganisms. In several embodiments, such compositions are effective in treating drug resistant infectious diseases, for example, MRSA.Type: ApplicationFiled: February 17, 2012Publication date: June 14, 2012Inventors: Rodney Benjamin, Jeffrey Varelman, Anthony Keller
-
Publication number: 20110312875Abstract: The present invention provides a compound of formula I, II, III and IV as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.Type: ApplicationFiled: August 2, 2011Publication date: December 22, 2011Applicant: UNIVERSITY OF WOLLONGONGInventors: Timothy Patrick Boyle, John Barnard Bremner, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
-
Patent number: 8039430Abstract: The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.Type: GrantFiled: September 21, 2005Date of Patent: October 18, 2011Assignee: University of WollongongInventors: Timothy Patrick Boyle, John Barnard Bremner, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Joseph Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
-
Publication number: 20080300287Abstract: The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.Type: ApplicationFiled: September 21, 2005Publication date: December 4, 2008Applicant: UNIVERSITY OF WOLLONGONGInventors: Timothy Patrick Boyle, John Barnard Bremner, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
